Breast coil allows intervention
Confirma is showing at the RSNA meeting its breast MR coil enhanced with interventional components. Launched at RSNA 2006 as a purely diagnostic device, the Access Breast Coil is now outfitted with a grid plate and stabilization plate, a configuration cleared in July by the FDA. The four-channel phased-array coil was also modified to improve patient comfort, reduce weight, and increase physician access to the patient. The version slated for the RSNA exhibit floor is certified for use on Siemens Avanto, Espree, and Symphony MR scanners.
Confirma is showing at the RSNA meeting its breast MR coil enhanced with interventional components. Launched at RSNA 2006 as a purely diagnostic device, the Access Breast Coil is now outfitted with a grid plate and stabilization plate, a configuration cleared in July by the FDA. The four-channel phased-array coil was also modified to improve patient comfort, reduce weight, and increase physician access to the patient. The version slated for the RSNA exhibit floor is certified for use on Siemens Avanto, Espree, and Symphony MR scanners.
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
Could AI-Powered Abbreviated MRI Reinvent Detection for Structural Abnormalities of the Knee?
April 24th 2025Employing deep learning image reconstruction, parallel imaging and multi-slice acceleration in a sub-five-minute 3T knee MRI, researchers noted 100 percent sensitivity and 99 percent specificity for anterior cruciate ligament (ACL) tears.
New bpMRI Study Suggests AI Offers Comparable Results to Radiologists for PCa Detection
April 15th 2025Demonstrating no significant difference with radiologist detection of clinically significant prostate cancer (csPCa), a biparametric MRI-based AI model provided an 88.4 percent sensitivity rate in a recent study.
